Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer
Clinical trial NCT06387810 · UNKNOWN
Trial details
- NCT number
- NCT06387810
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-17
- Primary completion
- 2026-04-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.